Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
AI Program Aims to Break Barriers for Female Students

AI Program Aims to Break Barriers for Female Students

A new program, backed by Cornell Tech, M.I.T. and U.C.L.A., helps prepare lower-income, Latina and Black female computing majors for artificial intelligence careers.